RB1 and breast cancer: In summary, CMHE exhibited promising anti-BC effects in vitro and in vivo. CMHE suppressed the growth of human BC cells through triggering cell cycle arrest at G0/G1 and apoptotic cell death by inhibiting the Cyclin D1/CDK4-Rb pathway, generating the anti-BC effect of CMHE.